Discover the complete record of transactions filed by 王轲, Chief Executive Officer. Officer active across 1 companies, notably 千红制药. In total, 138 filings have been published. The latest transaction was filed on 11 May 2026 (Sale). Regulator: AMF. The full history is openly available.
Wang Ke is the General Manager and a Director at Qianhong Pharmaceutical. He is responsible for the overall management of the company and the implementation of its strategy. His leadership and expertise in the pharmaceutical industry are essential for the company's growth and innovation.